Jodélia Lima Martins Henriques
Federal University of Rio de Janeiro
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jodélia Lima Martins Henriques.
Thyroid | 2009
Patrícia de Fátima dos Santos Teixeira; Monica Dias Cabral; Nathalie Silva; Débora Vieira Soares; Valeria Bender Braulio; Ana Paula Cony Barros Couto; Jodélia Lima Martins Henriques; Antonio José Leal Costa; Alexandru Buescu; Mario Vaisman
BACKGROUND The relationship between thyroid status, including subclinical hypothyroidism (SH) and serum leptin is controversial or uncertain. Therefore we evaluated serum leptin in SH and overt hypothyroidism (OH) and determined the effects of levothyroxine (LT(4)) replacement on serum leptin in these disorders. METHODS Serum leptin, thyrotropin (TSH), free thyroxine, insulin, glucose, and body composition parameters were compared in 55 SH, 20 OH, and 28 euthyroid (EU) pre- and postmenopausal women. In addition, the effect of LT(4) treatment on serum leptin in SH and OH was assessed. RESULTS The mean +/- SD (median) serum leptin concentrations in the OH and SH groups were higher than in the EU group (35.1 +/- 27.2 [33.0] and 36.6 +/- 21.9 [30.6] ng/mL, respectively, vs. 23.2 +/- 19.3 [17.9] ng/mL, p = 0.011), but the difference was only significant in postmenopausal women. The body mass index (BMI), fat mass index (FMI), and the homeostasis model assessment-insulin resistance (HOMA-IR) index values were not different among these groups. In premenopausal women there was no correlation between leptin, BMI, or FMI and serum TSH levels (r(s) = 0.009, p = 0.474; r(s) = 0.043, p = 0.367; r(s) = 0.092, p = 0.232). In the postmenopausal women, the partial correlation coefficient between TSH and leptin was present, even when controlling for BMI (r(s) = 0.297, p = 0.042) and FMI (r(s) = 0.275, p = 0.050). LT(4) treatment was associated with a reduction of serum leptin concentrations in the OH group (p = 0.008). In SH group there were no differences between LT(4) replacement or no treatment, since a fall in serum leptin levels was detected in both SH subgroups, despite a more pronounced fall with LT(4) use. Treatment of the SH and OH groups with LT(4) did not influence HOMA-IR index or body composition. CONCLUSIONS Serum leptin concentrations are elevated in postmenopausal women with SH or OH. A relationship between thyroid status and serum leptin is further supported by the fact that LT(4) treatment, to restore the EU status, reduced serum leptin levels in OH in the absence of significant effects on BMI. In women, hypothyroidism influences either leptin secretion or degradation and this effect is more pronounced in postmenopausal than in premenopausal women.
Arquivos Brasileiros De Endocrinologia E Metabologia | 2007
Carla Amaral de Almeida; Patrícia de Fátima dos Santos Teixeira; Débora Vieira Soares; Monica Dias Cabral; Sheila Mamede Da Costa; Elizabeth Salles; Nathalie Silva; Felipe Fernandes Cordeiro de Morais; Alexandru Buescu; Jodélia Lima Martins Henriques; Mario Vaisman
Subclinical hypothyroidism (SH) has been associated with an increased risk for coronary disease. Carotid intima-media thickness (IMT), as assessed by ultrasonography, is a precise marker of atherosclerotic changes and can be used as an endpoint for cardiovascular events. Aims of this study were to determine carotid IMT in a group of patients with SH and its possible association with an increase in cardiovascular risk. There were no significant differences in mean carotid IMT between patients and controls. Results of both groups were, respectively: common carotid arteries, 0.573 +/- 0.070 mm and 0.576 +/- 0.068 mm (p= 0.904); carotid bifurcation, 0.602 +/- 0.079 mm and 0.617 +/- 0.102 mm (p= 0.714). Similar results were obtained when analyzing subgroups with serum TSH < or > 8 mIU/L and with positive or negative titers of TPOAb. The mean carotid IMT in these subgroups were: TSH 4-8 mIU/L: 0.579 +/- 0.070 mm and 0.586 +/- 0.063 mm; TSH > 8 mIU/L: 0.569 +/- 0.073 mm and 0.616 +/- 0.091 mm; TPOAb+: 0.585 +/- 0.070 mm and 0.621 +/- 0.085 mm; TPOAb-: 0.554 +/- 0.072 mm and 0.571 +/- 0.066 mm. No differences in the lipid profile and in the apoprotein B and lipoprotein (a) levels between the groups were found. These findings suggest that mild SH with no related metabolic changes is not associated with an increase in cardiovascular risk, as assessed by carotid IMT.
Radiologia Brasileira | 2001
Rosimere J. Teixeira; Valéria Cataldo Gomes da Silva; Josele R. Freitas; Jodélia Lima Martins Henriques; Marília M. Guimarães
Real-time high-resolution ultrasonography of the pelvic organs was performed in 140 healthy females aged 2-18 years. The aim of this study was to establish the prevalence of polycystic ovaries during normal pubertal development. The volume of the ovaries was calculated and ovarian structure was classified as homogeneous, microcystic, multycystic, polycystic and follicular. The volume of the ovaries increased and the ovarian structure varied according to sexual development. The ovaries exhibited a polycystic appearance in 8% of the cases (two prepubertal and nine postpubertal girls). The volume of the ovaries was normal in 8/11 patients with polycystic ovaries. We consider that the using of the volume of the ovaries as a diagnostic criterion for polycystic ovaries is difficult to interpret and we emphasize the importance of the evaluation of the ovarian stroma with ultrasound. An attractive hypothesis that needs confirmation by longitudinal studies is wether girls with ultrasound diagnosed polycystic ovaries are at risk of developing polycystic ovarian syndrome in adulthood.
Arquivos Brasileiros De Endocrinologia E Metabologia | 2008
Débora Vieira Soares; Luiz Tadashi Nakamura; Marcia Cristina Boaventura Ladeira; Selma M. Brito; Jodélia Lima Martins Henriques
Acute Hepatic Failure in a patient with Hyperthyroidism and Virus B Hepatitis: Recovery after plasmapheresis and Thyroidectomy – a Case Report.
Jornal De Pediatria | 2004
Maria Alice Neves Bordallo; Leandro D. Tellerman; Rodrigo Bosignoli; Fernando F. R. M. Oliveira; Fernanda Mussi Gazolla; Isabel Rey Madeira; José F.C. Zanier; Jodélia Lima Martins Henriques
Archive | 2003
Maria Claudia Peixoto; Giselle F. Taboada; Márcia Branco Wagman; Vaneska Spinelli Reuters; Ana Paula; V. Sieiro; Jodélia Lima Martins Henriques; Mario Vaisman
Arquivos Brasileiros De Endocrinologia E Metabologia | 2003
Marise Machado; Rosimere J. Teixeira; Lenora Leão; Ana Lúcia O. Tabet; Rogério Bosignoli; Jodélia Lima Martins Henriques
J. bras. patol | 1998
Jodélia Lima Martins Henriques; Mario Vaisman; Francisca G. de Carvalho
Arquivos Brasileiros De Endocrinologia E Metabologia | 1997
Rosangela Hohleuwerger; Maria Alice Neves Bordallo; Rosimere J. Teixeira; Helena M. Gazolla; Trude Dimetz; Jodélia Lima Martins Henriques
Arquivos Brasileiros De Endocrinologia E Metabologia | 1996
Rosangela Houleuwerger; Valéria Cataldo Gomes da Silva; Maria Alice Neves Bordallo; Jodélia Lima Martins Henriques; Helena M. Gazolla; Maria Teresa Zanella
Collaboration
Dive into the Jodélia Lima Martins Henriques's collaboration.
Patrícia de Fátima dos Santos Teixeira
Federal University of Rio de Janeiro
View shared research outputs